Stay updated on Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.

Latest updates to the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page
- Check6 days agoChange DetectedUpdated the ClinicalTrials.gov interface/revision label from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check43 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 in the history.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the record history. This reflects a version-control update to the study record rather than a change to study content.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded revision v3.4.2 and removed revision v3.4.1 in the history.SummaryDifference0.1%

- Check86 days agoChange DetectedThe history shows a new revision entry (v3.4.1) was added and the previous revision (v3.4.0) removed from the history; there are no substantive content changes to the study record, To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.